cancer treatment
Astellas prostate cancer drug gets third approval from MHRA
May 12, 2021Research and Development Astellas, MHRA, cancer research, cancer treatment, pharma, pharma news, prostate cancer
The MHRA has approved Astellas Pharma’s XTANDI (enzalutamide) drug for the treatment of a third form of prostate cancer, making …
NICE rejects Merck Serono’s Bavencio for urothelial cancer
May 10, 2021Sales and Marketing MSD, Merck, NHS, NICE, cancer treatment, pharma, pharma news
The use of avelumab for maintenance treatment of locally advanced or metastatic urothelial cancer after platinum-based chemotherapy is not recommended by …
Merck kidney and uterus cancer treatments granted priority review by FDA
May 7, 2021Medical Communications FDA, MSD, Merck, cancer treatment, kidney cancer treatment, pharma, pharma news, uterus cancer treatment
The FDA has granted priority review for Merck (MSD) and Eisai’s application for two new approvals for the combination of …
Researchers find possible new treatment for several cancers
April 23, 2021Medical Communications Cancer, The Institute of Cancer Research, cancer treatment, kidney cancer treatment, pharma, pharma news
Researchers at The Institute of Cancer Research (ICR) in London have discovered a new use for an ovarian and breast …
Amgen stomach cancer drug awarded Breakthrough Therapy Designation
April 21, 2021Research and Development Amgen, Cancer, cancer treatment, pharma, pharma news
Amgen’s investigational therapy, bemarituzumab, for certain types of stomach and esophagus cancer, has been granted Breakthrough Therapy Designation by the …
Exscientia enter first-ever AI cancer drug into Phase I trials
April 9, 2021Medical Communications AI, Evotec, Exscientia, cancer treatment, oncology, pharma, pharma news
Exscientia and Evotec have announced that they are entering an AI-designed immuno-oncology drug into Phase I trials for the first …
Takeda acquire Maverick in $525m deal to expand cancer therapy portfolio
March 10, 2021Research and Development Maverick, Takeda, cancer treatment
Takeda has acquired Maverick Therapeutics in a deal worth up to $525 million, in order to expand its portfolio of …
Merck and Debiopharm agree €898m deal to develop head and neck cancer treatments
March 1, 2021Sales and Marketing Debiopharm, Merck, cancer treatment, head and neck cancer, xevinapant
German science and technology company Merck have agreed a worldwide in-licensing agreement with Debiopharm for the development and commercialisation of …
ONK and Anthony Nolan combine forces to work on blood cancer therapies
February 22, 2021Sales and Marketing Anthony Nolan, Cancer, ONK, blood cancer, cancer treatment
ONK Therapeutics and blood cancer charity Anthony Nolan will work together on therapies for patients with haematological malignancies (blood cancers) …
New Cell Guidance technology has potential to help treat cancer
February 19, 2021Medical Communications Cancer, cancer treatment, cell guidance systems, macrophages, pharma news
Cell Guidance Systems’ new POlyhedrin Delivery System (PODS) technology has been shown to have therapeutic potential in the treatment of …
AI may help predict patient response to non-small cell lung cancer therapies
March 23, 2020Medical Communications, Sales and Marketing Cancer, Lesions, cancer treatment, tumour treatment
Researchers have used artificial intelligence to train algorithms to predict tumour sensitivity to systemic cancer therapies. Radiologists previously determined if …
Landmark study set to transform cancer treatment
February 6, 2020Business Services Cancer, cancer breast, cancer mutations, cancer research, cancer treatment
Over a thousand scientists have built the most detailed picture of cancer ever in a landmark study. Their research was …
China approves Roche cancer drug Kadcyla
January 22, 2020Business Services China, Roche, breast cancer, cancer treatment, oncology
China has approved the import of Roche’s drug for breast cancer, just after it recently won expanded approval in the …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
